Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: QTRX

Quanterix Corporation

Healthcare | Medical - Devices

No licensed closing price on file for QTRX. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

EPS (TTM)$-2.62

Quanterix Corporation (NASDAQ: QTRX) is a medical device company. Figures from SEC EDGAR; updated 2026-10-20 04:35 UTC.

What Quanterix Corporation does

This company is a life sciences organization that makes instruments, consumables, and services for detecting and analyzing protein biomarkers in biological samples. Its Simoa detection technology allows researchers to identify proteins at extremely low concentrations in blood and other fluids, while its spatial biology platforms enable scientists to study how cells and biomarkers interact within tissue samples.

Summarized from Quanterix Corporation’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Pre-revenue, development-stage company: standard profitability ratios (P/E, EV/EBITDA, ROE) do not apply yet because there are no earnings. Watch cash, cash runway, net loss, R&D spend and share dilution instead.

Key facts

Valuation
EPS (TTM)$-2.62

Revenue, margins & earnings

FY2021: net loss $58M on revenue $111M$111MFY2021FY2022: net loss $100M on revenue $106M$106MFY2022FY2023: net loss $28M on revenue $122M$122MFY2023FY2024: net loss $39M on revenue $137M$137MFY2024FY2025: net loss $107M on revenue $139M$139MFY2025
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
  • Net loss year
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-10-16
  • 2026-10-16Chief Technology OfficerOption exercise136—
  • 2026-10-16Chief Technology OfficerOption exercise372—
  • 2026-10-16Chief Technology OfficerRestricted Stock UnitOption exercise-136—
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Quanterix Corporation do?

This company is a life sciences organization that makes instruments, consumables, and services for detecting and analyzing protein biomarkers in biological samples.

When did QTRX last file with the SEC?

Quanterix Corporation's most recent SEC filing on record is a 8-K filed 2026-06-10. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 04:35 UTC. This page is also available as JSON at /api/data?ticker=QTRX and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for QTRX and 5,000+ tickers.

Create a free account — keep QTRX
For your agent
GET /api/data?ticker=QTRX

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt